{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:15Z","timestamp":1707523935048},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,2]]},"DOI":"10.7759\/cureus.46374","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:46:12Z","timestamp":1696275972000},"source":"Crossref","is-referenced-by-count":1,"title":["Nineteen-Month Immunity to Adverse Radiation Effects Following 5-Fraction Re-radiosurgery With 43.6 Gy for Local Progression After Prior 3-Fraction Radiosurgery for Brain Metastasis From Pan-Negative Lung Adenocarcinoma"],"prefix":"10.7759","author":[{"given":"Kazuhiro","family":"Ohtakara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04265-y","article-title":"Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)","volume":"162","author":"Yan M","year":"2023","unstructured":"Yan M, Lee M, Myrehaug S, et al.. Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS). J Neurooncol. 2023, 162:119-28. 10.1007\/s11060-023-04265-y","journal-title":"J Neurooncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3171\/2022.4.JNS212597","article-title":"Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases","volume":"138","author":"Sneed PK","year":"2023","unstructured":"Sneed PK, Chan JW, Ma L, et al.. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases. J Neurosurg. 2023, 138:104-12. 10.3171\/2022.4.JNS212597","journal-title":"J Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42299","article-title":"5-fraction re-radiosurgery for progression following 8-fraction radiosurgery of brain metastases from lung adenocarcinoma: importance of gross tumor coverage with biologically effective dose \u226580 Gy and internal dose increase","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Tanahashi K, Kamomae T, Suzuki K. 5-fraction re-radiosurgery for progression following 8-fraction radiosurgery of brain metastases from lung adenocarcinoma: importance of gross tumor coverage with biologically effective dose \u226580 Gy and internal dose increase. Cureus. 2023, 15:e42299. 10.7759\/cureus.42299","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44492","article-title":"Volumetric-modulated arc-based re-radiosurgery with simultaneous reduced-dose whole-brain irradiation for local failures following prior radiosurgery of brain oligometastases from small cell lung cancer","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Arakawa S, Nakao M, Muramatsu H, Suzuki K. Volumetric-modulated arc-based re-radiosurgery with simultaneous reduced-dose whole-brain irradiation for local failures following prior radiosurgery of brain oligometastases from small cell lung cancer. Cureus. 2023, 15:e44492. 10.7759\/cureus.44492","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.10.034","article-title":"Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases","volume":"110","author":"Redmond KJ","year":"2021","unstructured":"Redmond KJ, Gui C, Benedict S, et al.. Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2021, 110:53-67. 10.1016\/j.ijrobp.2020.10.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.03.050","article-title":"A pathology-based substrate for target definition in radiosurgery of brain metastases","volume":"66","author":"Baumert BG","year":"2006","unstructured":"Baumert BG, Rutten I, Dehing-Oberije C, et al.. A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys. 2006, 66:187-94. 10.1016\/j.ijrobp.2006.03.050","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33411","article-title":"Correlation of brain metastasis shrinking and deviation during 10-fraction stereotactic radiosurgery with late sequela: suggesting dose ramification between tumor eradication and symptomatic radionecrosis","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Tanahashi K, Kamomae T, Miyata K, Suzuki K. Correlation of brain metastasis shrinking and deviation during 10-fraction stereotactic radiosurgery with late sequela: suggesting dose ramification between tumor eradication and symptomatic radionecrosis. Cureus. 2023, 15:e33411. 10.7759\/cureus.33411","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35467","article-title":"An extremely inhomogeneous gross tumor dose is suitable for volumetric modulated arc-based radiosurgery with a 5-mm leaf-width multileaf collimator for single brain metastasis","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Suzuki K. An extremely inhomogeneous gross tumor dose is suitable for volumetric modulated arc-based radiosurgery with a 5-mm leaf-width multileaf collimator for single brain metastasis. Cureus. 2023, 15:e35467. 10.7759\/cureus.35467","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.38645","article-title":"Local control failure after five-fraction stereotactic radiosurgery alone for symptomatic brain metastasis from squamous cell lung carcinoma despite 43 Gy to gross tumor margin with internal steep dose increase and tumor shrinkage during irradiation","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Tanahashi K, Kamomae T, Ito E, Suzuki K. Local control failure after five-fraction stereotactic radiosurgery alone for symptomatic brain metastasis from squamous cell lung carcinoma despite 43 Gy to gross tumor margin with internal steep dose increase and tumor shrinkage during irradiation. Cureus. 2023, 15:e38645. 10.7759\/cureus.38645","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36680","article-title":"Five-year sustained complete remission with minimal adverse effects following radiosurgery for 2-cm brain metastasis with deep eloquent location from lung adenocarcinoma despite low marginal dose and high 12 Gy volume","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Nakao M, Muramatsu H, Suzuki K. Five-year sustained complete remission with minimal adverse effects following radiosurgery for 2-cm brain metastasis with deep eloquent location from lung adenocarcinoma despite low marginal dose and high 12 Gy volume. Cureus. 2023, 15:e36680. 10.7759\/cureus.36680","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.09.008","article-title":"Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer","volume":"85","author":"Matsuyama T","year":"2013","unstructured":"Matsuyama T, Kogo K, Oya N. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013, 85:984-90. 10.1016\/j.ijrobp.2012.09.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34831","article-title":"Modified dynamic conformal arcs with forward planning for radiosurgery of small brain metastasis: each double arc and different to-and-fro leaf margins to optimize dose gradient inside and outside the gross tumor boundary","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Suzuki K. Modified dynamic conformal arcs with forward planning for radiosurgery of small brain metastasis: each double arc and different to-and-fro leaf margins to optimize dose gradient inside and outside the gross tumor boundary. Cureus. 2023, 15:e34831. 10.7759\/cureus.34831","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-012-0834-3","article-title":"Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases","volume":"108","author":"Ohtakara K","year":"2012","unstructured":"Ohtakara K, Hayashi S, Nakayama N, Ohe N, Yano H, Iwama T, Hoshi H. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases. J Neurooncol. 2012, 108:201-9. 10.1007\/s11060-012-0834-3","journal-title":"J Neurooncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.08.013","article-title":"Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain","volume":"110","author":"Milano MT","year":"2021","unstructured":"Milano MT, Grimm J, Niemierko A, et al.. Single- and multifraction stereotactic radiosurgery dose\/volume tolerances of the brain. Int J Radiat Oncol Biol Phys. 2021, 110:68-86. 10.1016\/j.ijrobp.2020.08.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.113.7.969","article-title":"Bullous pemphigoid: clinical and serologic evaluation for associated malignant neoplasms","volume":"113","author":"Ahmed AR","year":"1977","unstructured":"Ahmed AR, Chu TM, Provost TT. Bullous pemphigoid: clinical and serologic evaluation for associated malignant neoplasms. Arch Dermatol. 1977, 113:969. 10.1001\/archderm.113.7.969","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11402","article-title":"CYFRA 21-1 as a predictive marker for non-small cell lung cancer treated with pemetrexed-based chemotherapy","volume":"37","author":"Sone K","year":"2017","unstructured":"Sone K, Oguri T, Nakao M, et al.. CYFRA 21-1 as a predictive marker for non-small cell lung cancer treated with pemetrexed-based chemotherapy. Anticancer Res. 2017, 37:935-9. 10.21873\/anticanres.11402","journal-title":"Anticancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43759","article-title":"Twenty-month regression following concurrent conventional whole-brain irradiation and chemoimmunotherapy for \u22653.8 cm cerebellar metastasis from small cell lung cancer","volume":"15","author":"Ohtakara K","year":"2023","unstructured":"Ohtakara K, Arakawa S, Nakao M, Muramatsu H, Suzuki K. Twenty-month regression following concurrent conventional whole-brain irradiation and chemoimmunotherapy for \u22653.8 cm cerebellar metastasis from small cell lung cancer. Cureus. 2023, 15:e43759. 10.7759\/cureus.43759","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2016-0117","article-title":"Use of systemic therapy concurrent with cranial radiotherapy for cerebral metastases of solid tumors","volume":"22","author":"Verduin M","year":"2017","unstructured":"Verduin M, Zindler JD, Martinussen HM, et al.. Use of systemic therapy concurrent with cranial radiotherapy for cerebral metastases of solid tumors. Oncologist. 2017, 22:222-35. 10.1634\/theoncologist.2016-0117","journal-title":"Oncologist"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(02)02773-6","article-title":"Gemcitabine-induced radiation recall","volume":"53","author":"Jeter MD","year":"2002","unstructured":"Jeter MD, J\u00e4nne PA, Brooks S, et al.. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002, 53:394-400. 10.1016\/s0360-3016(02)02773-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2022.09.005","article-title":"Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control","volume":"37","author":"Nakano T","year":"2022","unstructured":"Nakano T, Aoyama H, Onodera S, et al.. Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control. Clin Transl Radiat Oncol. 2022, 37:116-29. 10.1016\/j.ctro.2022.09.005","journal-title":"Clin Transl Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/188324-nineteen-month-immunity-to-adverse-radiation-effects-following-5-fraction-re-radiosurgery-with-436-gy-for-local-progression-after-prior-3-fraction-radiosurgery-for-brain-metastasis-from-pan-negative-lung-adenocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:03Z","timestamp":1707508383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/188324-nineteen-month-immunity-to-adverse-radiation-effects-following-5-fraction-re-radiosurgery-with-436-gy-for-local-progression-after-prior-3-fraction-radiosurgery-for-brain-metastasis-from-pan-negative-lung-adenocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.46374","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,2]]}}}